Similarly, current reports suggest that cancer cells maintain a higher NAD+/NADH ratio than non-cancerous cells,79 in part through increased NAMPT activity to enhance NAD + production.80,81 At first glance, this contrasts with our observation of a lower NAD+/NADH ratio and enhanced oncogenic capacity. Here, NAMPT is linked to cancer.